c-Fos Antibody
(Synonyms: FOS; G0S7; Proto-oncogene c-Fos; Cellular oncogene fos; G0/G1 switch regulatory protein 7)Based on 4 publication(s) in Google Scholar
c-Fos Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to c-Fos.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-P, ICC/IF, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 1*PBS (pH 7.3), 50% glycerol and 0.5% BSA. Preservative: 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) c-Fos Antibody
More-
WB
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|---|
| Dilution Ratio | 1:500-1:1000 | 1:50-1:100 | 1:50-1:200 | 1:10000 |
Product Details
c-Fos Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to c-Fos.
-
Host Rabbit
-
Clonality Polyclonal
-
Species ReactivityHuman, Mouse, Rat
-
Observed Molecular WeightObserved band size: 58 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 41 kDa
Entrez Gene: 2353 Human ; 14281 Mouse ; 314322 Rat
SwissProt: P01100 Human ; P01101 Mouse
OMIM: 164810 Human
Synthetic peptide corresponding to Human Fos.AA range:331-380
Endogenous
affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 1*PBS (pH 7.3), 50% glycerol and 0.5% BSA. Preservative: 0.02% sodium azide.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (4)
-
Journal Impact Factor
-
Most Recent
-
J Transl Med
Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts. [Abstract]2025 Jan 31;23(1):142. PMID: 39891171
c-Fos Antibody purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 31;23(1):142. [Abstract]
Representative Western blot images showing Nfatc1, Ctsk, Fos, Mmp9, and Actin in BMM lysates. Primary antibodies used were anti-Nfatc1 (1:1,000), anti-Fos (c-Fos Antibody, 1:1,000; overnight at 4 °C, HY-P80616), anti-Ctsk (1:1,000, HY-P81163) and anti-MMP9 (1:1,000).
-
J Inflamm Res
CCL20 Expression via AKT-ERK1/2-AP1 Pathway in Mycoplasma Pneumoniae Infection: Implications for EMT and Cell Migration. [Abstract]2025 Apr 28:18:5727-5739. PMID: 40322529 -
iScience
2026 Jun 2;29(6):116198. PMID: 42291205
Verification Images
-
Western blot analysis was performed on extracts from RAW264.7 (lane 1, 15 μg) using c-Fos Rabbit pAb.Proteins were transferred to a PVDF membrane and blocked with 5% non - fat milk in TBST at 4°C overnight.The primary antibody (1:1000 dilution) and the loading control antibody (beta-Actin, HY-P83730, 1:20000 dilution) were incubated in 5% non-fat milk in TBST for 1 hour at 37°C.Goat Anti - Rabbit IgG - HRP Secondary Antibody (1:20000 dilution) was then applied for 40 minutes at 37°C.
-
Western blot analysis of extracts from Hela (lane 2(20μg), Hela (lane 3(40μg), using c-Fos Antibody. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in TBST for 2 hour at room temperature. The primary antibody and Loading control antibody (Beta Actin, HY-P80438, 1/3000) was used in 5% BSA in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (HY-P8004/HY-P8001, 1/10,000) was used for 1 hour at room temperature.
-
Immunohistochemical analysis of paraffin-embedded Rat brain tissue using c-Fos Antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HY-P80616, 1/100) in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded Rat brain tissue using c-Fos Antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 8 minutes. The tissues were blocked in QuickBlock for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HY-P80616, 1/100) in 4℃ overnight. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Background
-
Function
c-Fos is an immediate-early gene product and transcription factor that functions as a central mediator of stimulus-dependent gene expression, linking transient extracellular signals to long-term cellular responses through regulation of downstream target genes[1]. Mechanistically, c-Fos belongs to the Fos family and forms the activator protein-1 (AP-1) transcription factor complex through dimerization with Jun family proteins, thereby regulating genes involved in cellular differentiation, proliferation, development, plasticity, and survival[4][3][2]. c-Fos expression is rapidly induced by neuronal activity, calcium- and cAMP-dependent signaling, and other environmental stimuli, making it a widely used molecular marker of cellular activation and stimulus-transcription coupling in experimental systems[1][3]. In disease and experimental models, c-Fos has been extensively employed to map activated neuronal populations during seizures, learning, memory formation, and behavioral responses, providing a framework for investigating neural circuit function and activity-dependent transcriptional programs[1][3]. Compared with related Fos family members, including FosB, Fra-1 (FOSL1), and Fra-2 (FOSL2), c-Fos contains a C-terminal transactivation domain and exhibits distinctive transcriptional regulatory properties within AP-1 complexes[4]. For experimental applications, c-Fos is primarily used as an activity-dependent biomarker rather than a direct pharmacological target, enabling quantitative assessment of cellular activation, neural network recruitment, and stimulus-responsive signaling pathways in neuroscience and molecular biology research[3][5].
-
Subcellular Localization
Nucleus; Endoplasmic reticulum; Cytoplasm, cytosol
-
Isoforms & Post-Translational Modification
P01100 has 3 isomers: P01100-1: 40695 Da (predicted); P01100-2: 28986 Da (predicted); P01100-3: 36301 Da (predicted).
Phosphorylated in the C-terminal upon stimulation by nerve growth factor (NGF) and epidermal growth factor (EGF). Phosphorylated, in vitro, by MAPK and RSK1. Phosphorylation on both Ser-362 and Ser-374 by MAPK1/2 and RSK1/2 leads to protein stabilization with phosphorylation on Ser-374 being the major site for protein stabilization on NGF stimulation. Phosphorylation on Ser-362 and Ser-374 primes further phosphorylations on Thr-325 and Thr-331 through promoting docking of MAPK to the DEF domain. Phosphorylation on Thr-232, induced by HA-RAS, activates the transcriptional activity and antagonizes sumoylation. Phosphorylation on Ser-362 by RSK2 in osteoblasts contributes to osteoblast transformation (By similarity);Constitutively sumoylated with SUMO1, SUMO2 and SUMO3. Desumoylated by SENP2. Sumoylation requires heterodimerization with JUN and is enhanced by mitogen stimulation. Sumoylation inhibits the AP-1 transcriptional activity and is, itself, inhibited by Ras-activated phosphorylation on Thr-232;In quiescent cells, the small amount of FOS present is phosphorylated at Tyr-10 and Tyr-30 by SRC. This Tyr-phosphorylated form is cytosolic. In growing cells, dephosphorylated by PTPN2. Dephosphorylation leads to the association with endoplasmic reticulum membranes and activation of phospholipid synthesis -
Subunit
Heterodimer; with JUN (By similarity). Component of the SMAD3/SMAD4/JUN/FOS complex required for synergistic TGF-beta-mediated transcription at the AP1 promoter site (PubMed:9732876). Interacts with SMAD3; the interaction is weak even on TGF-beta activation (PubMed:9732876). Interacts with MAFB (By similarity). Interacts with TSC22D3 (via N-terminus); this interaction inhibits the binding of active AP1 to its target DNA (By similarity). Interacts with CDS1 and PI4K2A (By similarity). Interacts (via bZIP domain and leucine-zipper region) with the multiprotein chromatin-remodeling complexes SWI/SNF: SWI/SNF-A (BAF) subunits SMARCB1, SMARCC2 and SMARCD1 (By similarity). Interacts (via bZIP domain and leucine-zipper region) with ARID1A (By similarity)
-
SwissProt ID
-
Synonyms
FOS; G0S7; Proto-oncogene c-Fos; Cellular oncogene fos; G0/G1 switch regulatory protein 7
-
Research Field
Neuroscience
Documentation
-
Data Sheet (261 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
User Guide for Antibodies (1077 KB)
[2]. Curran T, et al. Fos: an immediate-early transcription factor in neurons. J Neurobiol. 1995 Mar;26(3):403-12. [Content Brief]
[4]. Srivastava SK, et al. Genetic regulation of spy gene expression in Escherichia coli in the presence of protein unfolding agent ethanol. Gene. 2014 Sep 10;548(1):142-8. [Content Brief]
[5]. Cruz-Mendoza F, et al. Immediate early gene c-fos in the brain: focus on glial cells. Brain Sci. 2022;12(6):687. [Content Brief]
[6]. Lara Aparicio SY, et al. Current opinion on the use of c-Fos in neuroscience. NeuroSci. 2022;3(4):687-702. [Content Brief]